Examples of using Seroconversion in English and their translations into Greek
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Official/political
-
Computer
The concerns over the immunogenicity of the HepB component increased when lower than expected seroconversion rates were observed following the concomitant administration of Hexavac with other meningococcal and pneumococcal vaccines.
The seroconversion from HBeAg positivity to anti-HBe positivity indicates a reduced level of infectious virus because virus replication has decreased.
Relative risk reduction calculated on incident(post-baseline) seroconversion from the double-blind treatment period and through the 8-week follow-up period.
hepatitis B vaccines were administered concomitantly with specific immunoglobulins there was no effect on seroconversion rates.
The seroprotection rate, the seroconversion rate and seroconversion factor for anti-HA antibody were as follows.
HBsAg persists for 6-12 months with no seroconversion to the corresponding antibodies.
No scientific arguments are available concerning how the additional testing would minimise the risk of possible seroconversion induced by the vaccine.
Seroconversion rates and geometric mean titers of IXIARO
second dose of the vaccine, the seroprotection rate, the seroconversion rate and seroconversion factor for anti-haemagglutinin(anti-HA) antibody were as follows.
Table 12: Seroconversion rates and geometric mean titer of JEV neutralizing antibody by vaccine dose
At day 42, the anti-HA antibody seroconversion rate was 98%, all subjects were seroprotected and the seroconversion factor was 88.6.
Seroprotection rate Seroconversion rate Seroconversion factor* measured by SRH assay≥ 25 mm** geometric mean ratios of SRH.
Seroconversion rates for measles,
Two years after primary vaccination seroconversion rates were 93.4% for measles,
The seroprotection rate, the seroconversion rate and the seroconversion factor, using haemagglutination inhibiting(HI)
In HBeAg negative patients, treatment should be administered at least until HBs seroconversion or there is evidence of loss of efficacy.
The seroprotection rates, seroconversion rates and seroconversion factors for anti-haemagglutinin(anti-HA) antibody at day 42(post dose 2)
consequently the risk of seroconversion against the listed agents is also concluded to be low.
In these studies seroconversion in response to vaccination against measles,
a competitive yellow fever vaccine and the seroconversion rate and adverse event profile was similar.